Bill

Bill > S1432


MA S1432

Relative to LSDs (Lysosomal Storage Disorders) in infants


summary

Introduced
03/29/2021
In Committee
03/29/2021
Crossed Over
Passed
Dead
12/31/2022

Introduced Session

192nd General Court

Bill Summary

For legislation relative to LSDs (Lysosomal Storage Disorders) in infants. Public Health.

AI Summary

This bill amends Section 110A of Chapter 111 of the General Laws to add several Lysosomal Storage Disorders (LSDs) to the list of conditions that require newborn screening tests, including Krabbe, Fabry, Gaucher, Pompe, MPS I, and Niemann Pick A/B diseases. LSDs are a group of rare genetic disorders that result from deficiencies in specific enzymes, leading to the buildup of certain substances in the body's cells. Requiring newborn screening for these conditions can help identify and treat them early, improving health outcomes for affected infants.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

Accompanied a study order, see S2692 (on 02/14/2022)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...